3 explosive small cap ASX shares to buy this week

Volpara Health Technologies Ltd (ASX:VHT) shares are one of three at the small end of the market that I think are in the buy zone…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

If your risk profile allows you to invest in small cap shares then I think the three listed below could be great options.

All three shares have been growing at an explosive rate over the last couple of years and have significant long-term growth potential.

Here's why I think they are worth considering:

ELMO Software Ltd (ASX: ELO)

ELMO is one of Australia and New Zealand's leading providers of integrated cloud human resources and payroll software solutions. Its software-as-a-service (SaaS), cloud-based platform provides businesses with a centralised approach to managing an employee's lifecycle from hire to retire. Strong demand for its services led to the company delivering impressive growth across all metrics in FY 2018. Pleasingly, this is expected to be the case in FY 2019 with management providing revenue guidance of $39.5 million, which will be a year on year increase of 24%.

Megaport Ltd (ASX: MP1)

Megaport is a provider of elastic interconnection services across a growing number of data centres globally and counts the likes of blue-chip companies such as AON, News Corp, and Breville Group Ltd (ASX: BRG) as customers. Due to the cloud computing market growing at an incredible rate and data consumption rising fast, I expand demand for its services to grow strongly in the future. Megaport has had a positive start to FY 2019 and recently reported a 20% increase in its monthly recurring revenue to $2.4 million.

Volpara Health Technologies Ltd (ASX: VHT)

Volpara is a healthcare technology company providing a breast imaging analytics and analysis software which aims to more effectively indicate cancer in breasts with greater density, lifting the accuracy of diagnoses. Due to the popularity of the product, at the end of FY 2018 it had grown its U.S. market share to approximately 3.2%. Management isn't resting on its laurels and is aiming to grow its share to 9% this year. Due to its expanding footprint and the quality of the product, I believe it can achieve this target and generate another significant rise in annualised recurring revenues.

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of ELMOSFTWRE FPO. The Motley Fool Australia owns shares of and has recommended VOLPARA FPO NZ. The Motley Fool Australia has recommended ELMOSFTWRE FPO. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Speculative

Speculative

Bell Potter says this speculative ASX stock can rocket 40%

If you have a high tolerance for risk, then it could be worth checking out Vitrafy Life Sciences Ltd (ASX:…

Read more »

Man pointing an upward line on a bar graph symbolising a rising share price.
Speculative

Why this speculative ASX stock could rise ~50%

Bell Potter sees potential for big returns over the next 12 months.

Read more »

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face over these rising Tassal share price
Speculative

These speculative ASX mining stocks could rise 85%+

Bell Potter has put speculative buy ratings on these stocks this morning.

Read more »

surprised asx investor appearing incredulous at hearing asx share price
Speculative

'Blockbuster opportunity': This speculative ASX stock could rise 70%

Bell Potter thinks exciting times could be around the corner for this buy-rated high risk stock.

Read more »

A smiling businessman in the city looks at his phone and punches the air in celebration of good news.
Healthcare Shares

Buy this small cap ASX stock with a 'lucrative opportunity'

Bell Potter thinks this speculative stock could have major upside thanks to its US market opportunity.

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Speculative

Broker says this speculative ASX stock could rise over 200%

This high risk option could have major upside according to analysts.

Read more »

Vanadium Resources share price person riding rocket indicating share price increase
Speculative

Meet the speculative ASX stock tipped to rise 180%

Bell Potter thinks this share could almost triple in value.

Read more »

People sit in rollercoaster seats with expressions of fear, terror and exhilaration as it goes into a steep downward descent representing the Novonix share price in FY22
AI Stocks

Brainchip share price tumbles 40% in the past year. What's next?

Brainchip shares have had a topsy-turvy year. So, what’s next for this speculative ASX AI technology stock?

Read more »